FK Laboratoriz Company
FK Laboratoriz has developed a drug which is a new structure of a highly specific direct thrombin inhibitor. Its expected pharmacological effects correspond to those stipulated by international standards and enable the product to compete with other medicinal products available at the EEU market. The drug was developed with the use of a combination of computer-based simulation and chemosynthesis, which are modern and recognized methods applied in the pharmaceutical industry.
Founded Date:
2015-01-01
Last Funding Date:
2016-10-01
Industry:
Quantum Chemistry
Total Funding:
174000
Headquarters:
Moscow,Moscow City,Russian Federation,Europe
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
174000
Last Funding Total Usd:
174000
Last Funding Total Currency:
USD
Last Funding Total Value:
174000